Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 11, 1999, Pages 4031-4036

  Stowasser, M ^a   Huggard, P R ^a   Rossetti, T R ^a   Bachmann, A W ^a   Gordon, R D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

18 OXOHYDROCORTISONE; ALDOSTERONE; ANGIOTENSIN; CORTICOTROPIN; CREATININE; DEXAMETHASONE; GLUCOCORTICOID; POTASSIUM; RENIN; SODIUM;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; DEXAMETHASONE SUPPRESSION TEST; FAMILIAL DISEASE; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYBRID GENE; HYDROCORTISONE BLOOD LEVEL; HYPERALDOSTERONISM; HYPERTENSION; MALE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; STANDING;

EID: 0033310867     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.11.4031     Document Type: Article

References (35)

1. A chimeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
2. Familial forms broaden the horizons for primary aldosteronism
3. Glucocorticoid-remediable aldosteronism in a large kindred: Clinical spectrum and diagnosis using a characteristic biochemical phenotype
4. A PCR-based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type I
5. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism
6. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension
7. Rapid diagnosis of glucocorticoid suppressible hyperaldosteronism in infants and adolescents
8. Glucocorticoid-suppressible hyperaldosteronism: Effects of crossover site and parental origin of chimeric gene on phenotypic expression
9. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I
10. Variation of phenotype in patients with glucocorticoid-remediable aldosteronism
11. In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild type genes
12. Report of the Second Task Force on Blood Pressure Control in Children-1987
13. A radiommmunoassay for plasma aldosterone
14. Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects
15. Hybrid gene or hybrid steroids in the detection and screening for familial hyperaldosternism type I
16. Evidence for persistent wild type aldosterone synthase gene dysfunction in glucocorticoid-treated familial hyperaldosteronism type I
17. Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism
18. Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism
19. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone
20. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoidremediable aldosteronism
21. The changing clinical spectrum of primary aldosteronism
22. Mineralocorticoid hypertension
23. Primary aldosteronism: Update on diagnosis and treatment
24. Primary aldosteronism with normal aldosterone levels in blood and urine
25. The diagnostic value of the 24-hour integrated concentration of plasma aldosterone
26. Plasma aldosterone-plasma renin activity ratio: A simple test to identify patients with primary aldosteronism
27. Clinical and pathological diversity of primary aldosteronism including a new familial variety
28. Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism
29. Hereditary hypertension caused by chimeric gene duplications and ectopic expression of aldosterone synthase
30. Receptor binding and biological activity of 18-oxocortisol
31. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives
32. Alteration by oral contraceptives of normal menstrual changes in plasma renin activity, concentration and substrate
33. Plasma renin concentratiom, activity, and substrate in hypertension induced by oral contraceptives
34. Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey
35. Glucocorticoid-remediable aldosterordsm (GRA): Diagnosis, variability of phenotype and regulation of potassium homeostasis